image credit: Adobe Stock

Bayer opens California plant to make cell therapies

October 10, 2023

The new facility is the latest investment from Bayer into cell and gene therapy. Bayer has been investing hundreds of millions of dollars into its Berkeley location, recently launching a Cell Culture Technology Center and cell therapy labs.

Notably, the plant will backstop development of bemdaneprocel, which originated from Cambridge-based BlueRock.

Bayer first took a bet on the cell therapy when it took a stake in BlueRock, later agreeing to buy the rest of the company for $240 million in 2019. As it has with other acquisitions, the large pharma agreed to operate the biotech as an independent subsidiary to preserve its culture.

Read More on Biopharma Dive